Home › Lewy Body Dementia › Massachusetts
Lewy Body Dementia clinical trials in Massachusetts
3 studies for Lewy Body Dementia are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- and 1 more
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Natural History Study of Synucleinopathies
- Beth Israel Deaconess Medical Center, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915PET Imaging Evaluation of [11C]SY08
- MGH, Charlestown
RecruitingEarly phase 1Healthy volunteers welcome
Ages 50 to 80 · All sexes · Updated Dec 24, 2025 · NCT06098612From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.